I reported previously (Feb 2018) about the 5-mer peptide, developed by Professor David Naor of the Hebrew University of Jerusalem. Its potential to treat inflammatory and brain diseases has now been recognized by donors and an Israeli biotech which has signed contracts for clinical trials.
https://www.israel21c.org/inventor-of-4-disease-drug-hears-from-investors-readers/